Healthcare

1 company covered · 1 report, 1 in the last 30 days

Ratings across the sector

Companies

1
Showing 1–1 of 1 companies
PriceTarget
GALT Galectin Therapeutics Inc.Biotechnology Sell $3.64$1.70-53% $367M InitiationOct 9, 2026

Sign in to Penmark

Choose how you'd like to sign in.

Penmark staff

Sign in with your staff account to publish to the live site.